GlaxoSmithKline Intellectual Property Development Limited
发明人:
Biggadike, Keith,Champigny, Aurelie Cecile,Coe, Diane Mary,Needham, Deborah,Tape, Daniel Terence
申请号：
AU2016212085
公开号：
AU2016212085B2
申请日:
2016.01.27
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
A compound of formula (I) Or a pharmaceutically acceptable salt and tautomers thereof, compositions, combinations and medicaments containing said compounds and processes for their preparation. The invention also relates to the use of said compounds, combinations, compositions and medicaments, in the treatment of diseases and conditions in which modulation of STING (Stimulator of Interferon Genes) is beneficial, for example inflammation, allergic and autoimmune diseases, infectious diseases, cancer, pre-cancerous syndromes and as vaccine adjuvants.
